NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
No results found when searching the local formulary, see alternative searches below.
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Aldesleukin Aldesleukin [Specialist Drug] Malignant Disease, Immunostimulants, Interleukins
Immunotherapy Responsive Malignancy
Bacillus Bacillus Calmette-Guérin [Specialist Drug] Malignant Disease, Immunostimulants, Immunostimulants, Other
Immunotherapy Responsive Malignancy
Interferon  Interferon Gamma-1B Malignant Disease, Immunostimulants, Interferons
Immunotherapy Responsive Malignancy
Lenalidomide Lenalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
Mifamurtide Mifamurtide [Specialist Drug] Malignant Disease, Immunostimulants, Immunostimulants, Other
Immunotherapy Responsive Malignancy
Pomalidomide Pomalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
Talimogene Talimogene Laherparepvec [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Antineoplastics, Other
Immunotherapy Responsive Malignancy
Thalidomide Thalidomide [Specialist Drug] Malignant Disease, Immunosuppressants, Thalidomide And Related Analogues
Immunotherapy Responsive Malignancy
No exact matches found - Possible matches - use with care.
Status Description Section
 Imuderm® emollient  Skin, Emollients, 13.02.01
 Indermil®  Skin, Skin tissue adhesive, 13.10.05
REDInterferon Beta Avonex® Malignant disease and immunosuppression, Interferon beta, 08.02.04
REDInterferon Beta Rebif® Malignant disease and immunosuppression, Interferon beta, 08.02.04
REDInterferon Beta 300mcg Betaferon® Malignant disease and immunosuppression, Interferon beta, 08.02.04 Subcutaneous injection
 INTERFERON GAMMA-1b Immukin® Immunological products and vaccines, Interferons, 14.05